Systems announced the signing of an agreement with a global pharmaceutical company. The agreement is intended for KORU ...

The Boston-area company’s previous raises were also aimed at getting its investigational antibody treatment for inclusion ...

Systems (Nasdaq:KRMD) announced today that it signed a development agreement with a global pharmaceutical company.

The agreement is intended for KORU Medical to develop and seek regulatory clearance for a next-generation subcutaneous immunoglobulin (SCIg) therapy infusion system for use with a commercialized ...

National Institutes of Health (NIH) scientists and their colleagues report that a single dose of a broadly neutralizing ...

KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and ...

Health insurers process more than five billion payment claims annually, federal figures show. About 850 million are denied, ...

CSL Behring's gene therapy Hemgenix four years post-infusion data continue to show sustained efficacy and safety in adults with haemophilia B: King of Prussia, Pennsylvania Monday ...

With an increasing understanding of the underlying pathogenetic mechanisms and identification of specific therapeutic targets, monoclonal antibody treatment has been an ideal strategy for inducing ...

CSL Limited (OTC:CSLLY) and uniQure Inc (NASDAQ:QURE) announced the four-year results from the pivotal HOPE-B study ...